Doxanano
Develops radiation-activated nanoparticle drug delivery for patients with solid tumors
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-09
About Doxanano
Doxanano develops DXN polymer-based nanoparticles designed to carry chemotherapy drugs and release them locally when exposed to X-rays. Its Remotely Activated Chemotherapy approach combines the nanoparticles with radiotherapy to target tumor tissue while limiting exposure to healthy tissues.
The company is based in Pessac, France, and was founded in 2023. Its team includes scientists in polymer chemistry and nanomedicine, and it has advertised a Drug Delivery R&D Engineer position in Pessac.
Product: DXN polymer-based nanoparticles and a radiotherapy-activated chemotherapy drug-delivery approach for solid tumors.
Jobs at Doxanano
More biotech & pharma companies
Edelris
Drug discovery CRO offering compound libraries, screening and medicinal chemistry to pharma and biotech teamsNew on EvolcEffik
Women's health and intimate care products sold by a French pharmaceutical laboratory, founded in 1992 near ParisNew on EvolcEisai
Develops pharmaceutical therapies in oncology and neurology for patients with serious diseasesNew on EvolcEligo Bioscience
In vivo microbiome gene-editing technologies for developing targeted therapies for human diseaseNew on EvolcEmka Technologies
Telemetry, ECG and physiological monitoring systems and software for preclinical research labs working with rodents and large animalsNew on EvolcRemote-friendlyEmulseo
Microfluidic chemicals and custom development services for research, diagnostics and industrial applicationsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.